Article
Pediatric Myelodysplastic Syndromes.
Clinics in laboratory medicine - 1 Sept 2021
Patel Sanjay S
Abstract excerpt
Pediatric myelodysplastic syndromes (MDS) comprise less than 5% of childhood malignancies. Approximately 30% to 45% of pediatric MDS cases are associated with an underlying genetic predisposition syndrome. A subset of patients present with MDS/acute myeloid leukemia (AML) following intensive chemotherapy for an unrelated malignancy. A definitive diagnosis of MDS can often only be rendered pending a comprehensive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
